Dr. Jan Burger from the MD Anderson Cancer Center spoke to me about his research on ibrutinib resistance in chronic lymphocytic leukemia at the ASH (American Society of Hematology) Annual Meeting in December 7, 2014. TAKE AWAY POINTS: The number of patients with resistance to ibrutinib is small, but